Novo Nordisk A/S (ADR) news

   Watch this stock
Showing stories 1 - 3 of about 3   

Articles published

NVO 56.65 +0.44 (0.78%)
price chart
This Top-Performing Stock is Tackling One of the World's Deadliest Diseases
And when it comes to insulin, the market leader is undoubtedly Novo Nordisk A/S (NYSE:NVO), a global health care pharmaceutical company with more than 85 years in the market.
Related articles »  
Morning News: Z, DG, NVO, LVS, ADT, CAG, RAH, DDS, PLCE, STO, XOM, CS
Insulin maker Novo Nordisk A/S (ADR) (NYSE:NVO) reported positive data on its liraglutide-based therapy for type 2 diabetes.
Related articles »  
China Drug Market to Boom � Diabetes Alone a $3.2 Billion Business by 2016
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc. Disqus seems to be taking longer than usual.
Related articles »